Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

Michaela Döring(University Children's Hospital Tübingen), Ingo Müller(Universität Hamburg), Astrid Kimmig(University Children's Hospital Tübingen), Rupert Handgretinger(STZ eyetrial), Annika Erbacher(University Children's Hospital Tübingen), Peter Lang(STZ eyetrial), Carsten Müller(University Hospital Cologne), Pascal-David Johann(Heidelberg University), Carl-Philipp Schwarze(University Children's Hospital Tübingen)
BMC Infectious Diseases
October 19, 2012
10.1186/1471-2334-12-263
Cited by 65

Related Papers

Human Lymphoid and Myeloid Cell Development in NOD/LtSz- <i>scid IL2R</i> γ <i>null</i> Mice Engrafted with Mobilized Human Hemopoietic Stem Cells,
|The Journal of Immunology|2005|1.7k
Rational Extended Thermodynamics
|Springer Tracts in Natural Philosophy|1998|1.3k
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
|Blood|2010|430
A thermodynamic theory of mixtures of fluids
|Archive for Rational Mechanics and Analysis|1968|428
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
|The Lancet|2012|376